Enanta Pharma (ENTA) Misses Q2 EPS by 13c, updates expense guidance
Go back to Enanta Pharma (ENTA) Misses Q2 EPS by 13c, updates expense guidance| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 12.52 -0.18 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.70 | 52 Week High | $34.49 | |||
| Open | $12.67 | 52 Week Low | $20.39 | |||
| Day High | $12.84 | P/E | N/A | |||
| Day Low | $12.49 | EPS | $-3.18 | |||
| Volume | 277,684 | |||||

